Loomis, Sayles & Company’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-769,568
| Closed | -$48.8M | – | 718 |
|
|
2024
Q3 | $48.8M | Sell |
769,568
-11,134
| -1% | -$804K | 0.06% | 136 |
|
|
2024
Q2 | $52.7M | Sell |
780,702
-55,709
| -7% | -$3.89M | 0.07% | 108 |
|
|
2024
Q1 | $66.3M | Buy |
836,411
+41,739
| +5% | +$3.41M | 0.09% | 92 |
|
|
2023
Q4 | $61.8M | Buy |
794,672
+21,077
| +3% | +$1.56M | 0.09% | 99 |
|
|
2023
Q3 | $54.4M | Sell |
773,595
-11,452
| -1% | -$856K | 0.09% | 105 |
|
|
2023
Q2 | $62.5M | Sell |
785,047
-111,207
| -12% | -$8.04M | 0.1% | 97 |
|
|
2023
Q1 | $64.8M | Sell |
896,254
-224,834
| -20% | -$17.5M | 0.11% | 93 |
|
|
2022
Q4 | $92.3M | Sell |
1,121,088
-143,277
| -11% | -$11.8M | 0.18% | 65 |
|
|
2022
Q3 | $98.8M | Sell |
1,264,365
-13,444
| -1% | -$1.07M | 0.2% | 63 |
|
|
2022
Q2 | $86.4M | Buy |
1,277,809
+312,634
| +32% | +$21.8M | 0.16% | 66 |
|
|
2022
Q1 | $63.2M | Buy |
965,175
+334,491
| +53% | +$19.4M | 0.08% | 100 |
|
|
2021
Q4 | $38.3M | Sell |
630,684
-6,568
| -1% | -$392K | 0.05% | 214 |
|
|
2021
Q3 | $40.6M | Buy |
637,252
+133,720
| +27% | +$8.44M | 0.05% | 194 |
|
|
2021
Q2 | $31.6M | Buy |
503,532
+84,399
| +20% | +$5.29M | 0.04% | 238 |
|
|
2021
Q1 | $23.9M | Buy |
+419,133
| New | +$22.7M | 0.03% | 265 |
|
|
2016
Q4 | – | Sell |
-438,118
| Closed | -$21.7M | – | 1007 |
|
|
2016
Q3 | $21.7M | Buy |
438,118
+14,392
| +3% | +$750K | 0.06% | 234 |
|
|
2016
Q2 | $23.5M | Buy |
423,726
+51,656
| +14% | +$3.02M | 0.06% | 226 |
|
|
2016
Q1 | $20.5M | Buy |
372,070
+48,864
| +15% | +$2.79M | 0.06% | 255 |
|
|
2015
Q4 | $20.2M | Sell |
323,206
-1,441
| -0.4% | -$93.9K | 0.06% | 280 |
|
|
2015
Q3 | $21.5M | Sell |
324,647
-170,544
| -34% | -$13.1M | 0.06% | 257 |
|
|
2015
Q2 | $38.8M | Buy |
495,191
+17,684
| +4% | +$1.27M | 0.11% | 165 |
|
|
2015
Q1 | $34.2M | Sell |
477,507
-32,595
| -6% | -$2.09M | 0.09% | 189 |
|
|
2014
Q4 | $31.2M | Sell |
510,102
-69,838
| -12% | -$4.06M | 0.09% | 202 |
|
|
2014
Q3 | $28.1M | Sell |
579,940
-15,343
| -3% | -$750K | 0.08% | 214 |
|
|
2014
Q2 | $27.1M | Buy |
595,283
+24,944
| +4% | +$1.1M | 0.08% | 245 |
|
|
2014
Q1 | $25.7M | Sell |
570,339
-3,796
| -0.7% | -$187K | 0.07% | 265 |
|
|
2013
Q4 | $27.2M | Sell |
574,135
-5,329
| -0.9% | -$232K | 0.08% | 240 |
|
|
2013
Q3 | $22.8M | Buy |
579,464
+51,050
| +10% | +$1.89M | 0.07% | 278 |
|
|
2013
Q2 | $17.5K | Buy |
+528,414
| New | +$17.1M | 0.06% | 344 |
|
Other funds holding ACHC
PCP
MAP
Loomis, Sayles & Company's ACHC Position: Q4 2024 in Review
Loomis, Sayles & Company sold out of Acadia Healthcare (ACHC) in Q4 2024, closing a stake of 769,568 shares — an estimated $48.8M sold.
Loomis, Sayles & Company first reported a position in ACHC in Q2 2013 and held it in 29 quarters. The position peaked at $98.8M in Q3 2022. 306 funds tracked by Wall St. Rank hold ACHC as of Q4 2024.
- Loomis, Sayles & Company reported no remaining Acadia Healthcare position as of Q4 2024 after selling out during the quarter.
- Loomis, Sayles & Company sold 769,568 Acadia Healthcare shares in Q4 2024, an estimated $48.8M.
- Loomis, Sayles & Company first reported a position in Acadia Healthcare in Q2 2013 and held it in 29 quarters.
- Loomis, Sayles & Company's Acadia Healthcare position peaked at $98.8M in Q3 2022.
- 306 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2024.
Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.